Skip to content
Recall Observatory FDA recall evidence

Drug product

Olanzapine Tablets, 20 mg, packaged in a) 30-count bottles (NDC 62756-556-83), b) 100-count bottles (NDC 62756-556-88), and c) 1000-count bottles (NDC 62756-556-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India.

D-0702-2017

March 22, 2017

Class III

Product summary

Firm
Sun Pharmaceutical Industries, Inc.
Event
Event 76819
Status
Terminated
Classification
Class III
Quantity
14,784 bottles
Official record key
drug-enforcement:D-0702-2017

Official wording

Reason: Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Code information: Lot #: a) JKR5759A, Exp 04/18; b) JKP0943A, Exp 04/17, JKR5520A, Exp 04/18; c) JKP0988A, Exp 04/17

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification